share_log

国药控股(01099.HK)遭摩根大通减持117.1万股

Sinopharm Holdings (01099.HK) was reduced by 1.171 million shares by J.P. Morgan

Gelonghui Finance ·  May 9 07:00

Glonghui, May 9 | According to the latest equity disclosure data on the Stock Exchange, on May 2, 2024, Sinopharm Holdings (01099.HK) was reduced by JPMorgan Chase & Co. from a good position of 1.171 million shares at an average price of HK$19.4312 per share, involving an investment of about HK$22.754 million.

After reducing its holdings, JPMorgan Chase & Co.'s latest number of open positions was 798.571 million shares, and the holding ratio dropped from 6.03% to 5.95%.

Big

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment